JOVIC, Gordana
 Distribuzione geografica
Continente #
NA - Nord America 2.712
EU - Europa 1.427
AS - Asia 1.206
SA - Sud America 175
AF - Africa 40
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.563
Nazione #
US - Stati Uniti d'America 2.663
SG - Singapore 449
GB - Regno Unito 319
CN - Cina 281
IT - Italia 236
SE - Svezia 204
IE - Irlanda 190
VN - Vietnam 131
DE - Germania 127
HK - Hong Kong 125
BR - Brasile 124
RU - Federazione Russa 72
FI - Finlandia 68
UA - Ucraina 63
FR - Francia 51
TR - Turchia 39
IN - India 37
CA - Canada 26
BD - Bangladesh 25
LT - Lituania 22
BG - Bulgaria 21
KR - Corea 19
AR - Argentina 18
ID - Indonesia 14
NL - Olanda 13
IQ - Iraq 12
MX - Messico 12
ZA - Sudafrica 11
AE - Emirati Arabi Uniti 10
JP - Giappone 10
EC - Ecuador 9
CO - Colombia 8
ES - Italia 8
ET - Etiopia 8
PH - Filippine 8
PK - Pakistan 7
EG - Egitto 6
PL - Polonia 6
CL - Cile 5
MY - Malesia 5
SA - Arabia Saudita 5
IR - Iran 4
JO - Giordania 4
KE - Kenya 4
PT - Portogallo 4
RS - Serbia 4
SN - Senegal 4
UZ - Uzbekistan 4
AL - Albania 3
BE - Belgio 3
DO - Repubblica Dominicana 3
PY - Paraguay 3
TW - Taiwan 3
VE - Venezuela 3
AU - Australia 2
BO - Bolivia 2
GR - Grecia 2
HU - Ungheria 2
IL - Israele 2
LB - Libano 2
MA - Marocco 2
PA - Panama 2
TH - Thailandia 2
UY - Uruguay 2
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
HN - Honduras 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
ME - Montenegro 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
ST - Sao Tome e Principe 1
TJ - Tagikistan 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.563
Città #
Singapore 306
Ashburn 252
Santa Clara 238
Fairfield 219
Southend 201
Dublin 188
Chandler 182
Woodbridge 155
Houston 135
Dearborn 118
Hong Kong 117
San Jose 111
Nyköping 109
Jacksonville 100
Beijing 90
Seattle 86
Cambridge 81
Wilmington 71
Ann Arbor 68
New York 64
London 55
Los Angeles 46
Helsinki 45
Ho Chi Minh City 40
Council Bluffs 36
Chicago 34
Hanoi 30
Milan 28
Munich 27
The Dalles 26
San Diego 25
Izmir 24
Modena 24
Princeton 22
Eugene 19
Hefei 19
Sofia 19
Lauterbourg 17
Moscow 16
Salt Lake City 15
Shanghai 15
Jakarta 13
Rome 13
Seoul 13
Dallas 12
Denver 12
Dong Ket 12
Palermo 12
Des Moines 11
Lansdale 11
Buffalo 9
Da Nang 9
Guangzhou 9
Turku 9
York 9
Columbus 8
Orem 8
Phoenix 8
Tampa 8
Tokyo 8
Bremen 7
Brooklyn 7
Chengdu 7
Chennai 7
Stockholm 7
Atlanta 6
Frankfurt am Main 6
Montreal 6
Baghdad 5
Boardman 5
Elk Grove Village 5
Guayaquil 5
Johannesburg 5
Kunming 5
Mumbai 5
Nanjing 5
Naples 5
Porto Alegre 5
Redondo Beach 5
São Paulo 5
Tulsa 5
Warsaw 5
Amman 4
Amsterdam 4
Ankara 4
Bari 4
Belo Horizonte 4
Bologna 4
Dakar 4
Falls Church 4
Gallarate 4
Hải Dương 4
Kyiv 4
Norwalk 4
Ottawa 4
Redwood City 4
Rio de Janeiro 4
San Mateo 4
Augusta 3
Bangalore 3
Totale 3.860
Nome #
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 413
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 385
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 373
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA 368
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 364
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. 362
Letrozole Versus Letrozole Plus Lapatinib (GW572016) in Hormone-Sensitive, HER2-Negative Operable Breast Cancer: A Double-Blind, Randomized Phase II Study with Biomarker Evaluation (EGF109077-LAP107692/LETLOB) 357
CHER LOB Trial: Preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer--Safety report as per Independent Data Monitoring Committee (IDMC) and preliminary activity data 312
Prognostic and Predictive Value of Baseline and Posttreatment Molecular Marker Expression in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy 301
Middle turbinate preservation versus middle turbinate resection in endoscopic surgical treatment of nasal polyposis 297
Preoperative chemotherapy plus lapatinib or trastuzumab or both in Her2 positive operable breast cancer. EGF109085-LAP106988/CHERLOB Trial. 297
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer 253
PROLIFERATION AND APOPTOSIS BEFORE AND AFTER PRIMARY SYSTEMIC THERAPY FOR OPERABLE BREAST CANCER 253
Biomarker expression and survival after primary chemotherapy for breast cancer. 236
CHER-LOB: PREOPERATIVE CHEMOTHERAPY PLUS TRASTUZUMAB, LAPATINIB OR BOTH IN HER2-POSITIVE OPERABLE BREAST CANCER – PRELIMINARY SAFETY REPORT WITH FOCUS ON CARDIAC TOLERABILITY 229
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 220
LET-LOB: preoperative letrozole plus lapatinib or placebo in hormone-receptor positive HER2 negative operable breats cancer. Preliminary report of activity and cardiac tolerability 212
CHEMOTHERAPY-INDUCED MODULATION OF BIOMARKERS EXPRESSION IN PRIMARY BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 185
Final results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarker evaluation in operable breast cancer 174
Totale 5.591
Categoria #
all - tutte 18.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.663


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021108 0 0 0 0 0 0 0 0 0 36 40 32
2021/2022394 7 52 59 23 10 32 24 13 39 17 75 43
2022/2023679 88 82 32 56 45 59 21 36 215 4 8 33
2023/2024379 18 22 22 29 81 45 23 55 16 9 33 26
2024/2025891 28 21 10 79 169 151 52 59 121 39 61 101
2025/20261.658 102 47 109 229 409 116 215 80 176 175 0 0
Totale 5.591